loading page

Bone health in long-term survivors of acute lymphoblastic leukemia in children and ado-lecents. An assessment by peripheral quantitative computed tomography
  • +3
  • Ronald Barr,
  • Dean Inglis,
  • Uma Athale,
  • Maciej Jaworski,
  • Troy Farncombe,
  • Christopher Gordon
Ronald Barr
McMaster Children's Hospital
Author Profile
Dean Inglis
McMaster University
Author Profile
Uma Athale
McMaster University
Author Profile
Maciej Jaworski
Children's Memorial Health Institute
Author Profile
Troy Farncombe
hamilton Health Sciences
Author Profile
Christopher Gordon
Hamilton Health Sciences
Author Profile


Background – Loss of bone mineral is a common concomitant of the treatment of acute lymphoblastic leukemia (ALL) due mainly to chemotherapy, especially with corticosteroids. Osteopenia/osteoporosis may persist long into survivorship. Measurement of bone mineral density (BMD) by dual energy X-ray absorptiometry is limited to two-dimensionality and cannot distinguish trabecular from cortical bone. Methods – A sample of 74 subjects, more than 10 years from diagnosis, underwent peripheral quantitative computed tomography (pQCT) at metaphyseal (trabecular bone) and diaphyseal (cortical bone) sites in the radius and tibia. pQCT provides three-dimensional assessment of bone geometry, density and architecture. Results – Similarities of average values in multiple metrics with those in healthy subjects obscured deficits in both trabecular and cortical bone, as well as bone strength, revealed by Z scores using an ethnically comparable sample of healthy individuals. Connectivity, a measure of bone architecture and a surrogate measure of bone strength, was lower in females than males. Survivors of standard risk ALL had greater connectivity in and more compact trabecular bone than high risk survivors who had received more intensive osteotoxic chemotherapy. There were no statistically significant differences in any of the metrics at any of the sites between subjects who had or had not a history of fracture, cranial irradiation or use of a bisphosphonate. Conclusions – These long-term survivors of ALL have somehat compromised bone health, but data in comparable healthy populations are limited. Longitudinal studies in larger and more ethnically diverse cohorts will provide greater insight into bone health in this vulnerable population.

Peer review status:ACCEPTED

05 Apr 2021Submission Checks Completed
05 Apr 2021Assigned to Editor
05 Apr 2021Submitted to Pediatric Blood & Cancer
09 Apr 2021Reviewer(s) Assigned
28 Apr 2021Review(s) Completed, Editorial Evaluation Pending
01 May 2021Editorial Decision: Revise Major
28 May 2021Submission Checks Completed
28 May 2021Assigned to Editor
28 May 20211st Revision Received
31 May 2021Reviewer(s) Assigned
07 Jun 2021Review(s) Completed, Editorial Evaluation Pending
11 Jun 2021Editorial Decision: Accept